IL-5 and IL-5 Receptor in Asthma

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 75-91

  Kotsimbos, A T C ^a   Hamid, Q ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN RECEPTOR;

ANIMAL; ASTHMA; EOSINOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-5; RATS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 0031317776     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800012     Document Type: Article

References (159)

1. Al Assad AS, Yang JP, Hamid Q, Yasruel Z, Renzi PM 1995. Semi-quantitative analysis of cytokine mRNA in rat lungs after challenge. Am J Resp Crit Care Med 151.4: (A392).
2. Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay AB, Corrigan CJ 1994. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax 49: 1231-1233.
3. Azuma C, Tanabe T, Konishi M, Kinashi T, Noma T, Matsuda F, Yaoita Y, Takatsu K, Hammarstrom L, Smith CI 1986. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Research 14: 9149-9158.
4. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Assoufi B, Collins JV, Durham SR, Knowles GK, Kay AB 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 142: 1407-1413.
5. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB 1992. Identification of T lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 146: 500-506.
6. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, Kay AB, Durham SR 1996. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Resp Crit Care Med 153: 551-556.
7. Bentley AM, Durham SR, Kay AB 1994. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Investig Allergy & Clin Immunol 4: 222-232.
8. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for Interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am J Resp Cell Mol Biol 8: 35-42.
9. Bischoff SC, Brunner T, De Weck AL, Dahinden CA 1990. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 172: 1577-1582.
10. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani A-MA, Schwartz LB, Durham SR, Jerffery PK, Kay AB 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjecs and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88: 661-674.
11. Bazan JF 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934-6938.
12. Boulay JL, Paul WE 1992. The interleukin-4-related lymphokines and their binding to hematopoietin receptors. J Biol Chem 267: 20525-20528.
13. Boulay JL, Paul WE 1992. The interleukin-4 family of lymphokines. Curr Opin Immunol 4: 294-298.
14. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P 1990. Eosinophilic inflammation in asthma. New Engl J Med 323: 1033-1039.
15. Broide DH, Paine MM, Firestein GS 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 1414-1424.
16. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG 1989, Association of asthma with serum IgE levels and skin-test reactivity to allergens. New Engl J Med 320:271-277.
17. Butcher BT, O'Neil CE, Reed MA, Salvaggio JE 1980. Radioallergosorbent testing of toluene diisocyanatereactive individuals using p-tolyl isocyanate antigen. J Allergy & Clin Immunol 66: 213-216.
18. Chen JX, Watanabe S, Muto A, Miyajima A, Yokota T, Arai K 1994. Activation of early response genes and cell proliferation by human interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 receptors: comparison with human interleukin-4 receptor signaling. J Allergy & Clin Immunol 94: 605-611
19. Clutterbuck EJ, Hirst EM, Sanderson CJ 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 73: 1504-1512.
20. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245: 308-310.
21. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182: 1169-1174.
22. Cornelis S, Fache I, Van der Heyden J, Guisez Y, Tavernier J, Devos R, Fiers W, Plaetinck G 1995. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction. Eur J Immunol 25: 1857-1864.
23. Corrigan, CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S, Gemou-Engesaeth V, Kay AB 1995. Peripheral blood CD4 but not CD8 T-lymphocyte in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th-2 type pattern: Effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 12: 567-578.
24. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109-117.
25. Das AM, Williams TJ, Lobb R, Nourshargh S 1995. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology 84: 41-46.
26. Denburg JA, Silver JE, Abrams JS 1991. Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood 77: 1462-1468.
27. Dent LA, Strath M, Mellor AL, Sanderson CJ 1990. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172: 1425-1431.
28. Desreumaux P, Janin A, Dubucquoi S, Copin MC, Torpier G, Capron A, Capron M, Prin L 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82: 1553-1560.
29. Devos R, Plaetinck G, Cornelis S, Guisez Y, Van der Heyden J, Tavernier J 1995. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease. J Leuk Biol 57: 813-819.
30. Devos R, Guisez Y, Plaetinck G, Cornelis S, Tavernier J, Van der Heyden J, Foley LH, Scheffler JE 1994. Covalent modification of the interleukin-5 receptor isothiazolones leads to inhibition of binding of interleukin-5. Eur J Bioch 225: 635-640.
31. Devos R, Guisez Y, Cornelis S, Verhee A, Van der Heyden J, Manneberg M, Lahm H-W, Fiers W, Tavernier J, Plaetnick G 1993. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules: cross-linking and stoichiometry of binding to IL-5. J Biol Chem 268: 6581-6587.
32. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF 1995. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 37: 242-246.
33. Dunnill MS 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27-33.
34. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA 1992.Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 148: 2390-2394.
35. Egan RW, Athwahl D, Chou CC, Emtage S, Jehn CH, Kung TT, Mauser PJ, Murgolo N, Bodmer MW 1995. Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. Intern Arch Allergy & Immunol 107: 321-322.
36. Eidelman, DH, Minshall E, Dandurand RJ, Schotman E, Song YL, Yasruel Z, Moqbel R, Hamid Q 1996. Evidence for major basic protein immunoreactivity and IL-5 gene activation during the late phase response in explanted airways. Am J Respir Cell Mol Biol 15: 582-589.
37. Elices, MJ, Osborn L, Takadu Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR 1990. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 60: 577-584.
38. Endo H, Iwamoto I, Nakajima H, Yoshida S 1993. In vitro interleukin-5 production of peripheral blood mononuclear cells is increased in patients with asthma. Intern Arch Allergy & Immunol 101: 425-430.
39. Eum SY, Haile S, Lefort J, Huerre M, Vargaftig BB 1995. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Nat Acad Sci Unit Stat Am 92: 12290-12294.
40. Ewart SL, Mitzner W, DiSilvestre DA, Meyers DA, Levitt RC 1996. Airway hyperresponsiveness to acetylcholine: segregation analysis and evidence for linkage to murine chromosome 6. Am J Resp Cell & Mol Biol 14: 487-495.
41. Frew AJ, Kay AB 1988. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 141: 4158-4164.
42. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ 1990. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 144: 642-646.
43. Fukuda T, Nakajima H, Fukushima Y, Akutsu I, Numao T, Majima K, Motojima S, Sato Y, Takatsu K, Makino Syeau Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J Allergy & Clin Immunol 94: 584-593.
44. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201.
45. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Resp Dis 146: 263-266.
46. Hagan JB, Bartemes KR, Kita H, Ottesen EA, Awadzi K, Nutman TB, Gleich GJ 1996. Elevations in granulocyte-macrophage colony-stimulating factor and interleukin-5 levels precede posttreatment eosinophilia in onchocerciasis. J Infect Dis 173: 1277-1280.
47. Hamid Q, Boguniewicz M, Leung DY 1994. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94: 870-876.
48. Hamid Q, Song YL, Minshall E, Bai TR, Hegele RG, Hogg JC 1996. Small airways inflammation in asthma. Am J Resp Crit Care Med 153.4: (A878).
49. Hamid Q, Azzawi M, Sun Ying, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87: 1541-1546.
50. Humbert M 1996. Airways inflammation in asthma and chronic bronchitis. Clin & Exp Allergy 26: 735-737.
51. Humbert M, Grant JA, Tabordabarata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB 1996. High-affinity Ige receptor (Fe-epsilon-ri)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Resp & Crit Care Med 153: 1931-1937.
52. Humbert M. Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, Pfister R, Menz G, Robinson DS, Kay AB, Corrigan CJ 1996. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against asthma being a distint immunopathological entity. Am J Resp & Crit Care Med 154: 1497-1504.
53. Ihle JN 1995. Cytokine receptor signalling. Nature 377: 591-594.
54. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O 1995. Signaling through the hematopoietic cytokine receptors. Ann Rev Immunol 13: 369-398.
55. Iwamoto I, Tomoe S, Tomioka H, Takatsu K, Yoshida S 1992. Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J Leuk Biol 52: 572-578.
56. Iwamoto T, Takatsu K 1995. Evaluation of airway hyperreactivity in interleukin-5 transgenic mice. Intern Arch Allergy & Immunol 108 Suppl 1: 28-30.
57. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB 1989. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 140: 1745-1753.
58. Jung T, Schauer U, Rieger C, Wagner K, Einsle K, Neumann C, Heusser C 1995. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur J Immunol 25: 2413-2416.
59. Kamei T, Ozaki T, Kawaji K, Banno K, Sano T, Azuma M, Ogura T 1993. Production of interleukin-5 and granulocyte/macrophage colony-stimulating factor by T cells of patients with bronchial asthma in response to Dermatophagoides farinae and its relation to eosinophil colony-stimulating factor. Am J Resp Cell & Mol Biol 9: 378-385.
60. Karlen S, Dercole M, Sanderson CJ 1996. Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element. Blood 88: 211-221.
61. Kay AB, Ying S, Durham SR 1995. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions. Intern Arch Allergy & Immunol 107: 208-210.
62. Kay AB, Ying S, Durham SR 1995. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions. Intern Arch Allergy & Immunol 107: 208-210.
63. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173: 775-778.
64. Kelso A 1995. Th1 and Th2 subsets:paradigms lost? Immunology today 16.8: 374-379.
65. Kita H, Sur S, Hunt LW, Edell ES, Weiler DA, Swanson MC, Samsel RW, Abrams JS, Gleich GJ 1996. Cytokine production at the site of disease in chronic eosinophilic pneumonitis. Am J Resp & Crit Care Med 153: 1437-1441.
66. Klink M, Cline MG, Halonen M, Burrows B 1990. Problems in defining normal limits for serum IgE. J Allergy & Clin Immunol 85: 440-444.
67. Koike M, Takatsu K 1994. IL-5 and its receptor: which role do they play in the immune response, Int Arch Allergy Immunol 104: 1-9.
68. Kosugi H, Nakagawa Y, Hotta T, Saito H, Miyajima A, Arai K, Yokota T 1995. Structure of the gene encoding the alpha subunit of the human interleukin 3 receptor. Bioch & Biophys Res Comm 208: 360-367.
69. Krishnaswamy G, Liu MC, Su SN, Kumai M, Xiao HQ, Marsh DG, Huang SK 1993. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am J Resp Cell & Mol Biol 9: 279-286.
70. Kung, TT, Stelts DM, Zurcher JA, Adams III GK, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Resp Cell Mol Biol 13: 360-365.
71. Kuwano K, Bosken CH, Paré PD, Bai TR, Wiggs BR, Hogg JC 1993. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148: 1220-1225.
72. Laitinen LA, Laitinen A, Haahtela T. 1993. Airway muco sal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147: 697-704.
73. Laviolette M, Ferland C, Comtois JF, Champagne K, Bosse M, Boulet LP 1995. Blood eosinophil leukotriene C4 production in asthma of different severities. Eur Resp Journal 8: 1465-1472.
74. Lee HJ, Matsuda I, Naito Y, Yokota T, Arai N, Arai K 1994. Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells. J Allergy & Clin Immunol 94: 594-604.
75. Leung DM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q 1995. Dysregulation of Interleukin-4, Interleukin-5, and Interferon-g gene expression in steroid resistant asthma. J Exp Med 181: 33-40.
76. Limaye AP, Ottesen EA, Kumaraswami V, Abrams JS, Regunathan J, Vijayasekaran V, Jayaraman K, Nutman TB 1993. Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. J Infect Dis 167: 1396-1400.
77. Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, Gillis D, Ireland R, Olwell E, Park LS 1991. Interleukin-5, interleukin-3, and granulocyte-macrophage colony stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 266: 24741-24747.
78. Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Davas MA 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 167: 219-224.
79. Macklem PT, Proctor DF, Hogg JC 1970. The stability of peripheral airways, Resp Physiol 8: 191-203.
80. Mahanty S, Nutman TB 1993. The biology of interleukin-5 and its receptor. Cancer Investigation 11: 624-634.
81. Marini M, Avoni E, Hollemborg J, Mattoli S 1992. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 102: 661-669.
82. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK 3rd, Kreutner W, Egan RW, Chapman RW 1995. Effects of an antibody to inferleukin-5 in a monkey model of asthma. Am J Resp & Crit Care Med 152: 467-472.
83. McFadden ER Jr, Gilbert IA 1992. Asthma. New Engl J Med 327: 1928-1937.
84. Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN 1993. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature 363: 172-176.
85. Migita M, Yamaguchi N, Mita S, Higuchi S, Hitoshi Y, Yoshida Y, Tomonaga M, Matsuda I, Tominaga A, Takatsu K 1991. Characterization of the human IL-5 receptors on eosinophils. Cellular Immunology 133: 484-497.
86. Minshall E, Tsicopoulos A, Yasruel Z, Bernard A, Wallaert B, Vorng H, Tonnel A, Hamid Q 1996. High expression of cytoline gene transcripts in active pulmonary sarcoidosis compared to non-active pulmonary sarcodoisis and normal controls. Am J Respir Crit Care Med 153: A868.
87. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K 1992. Cytokine receptors and signal transduction. Ann Rev Immunol 10: 295-331.
88. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86: 1437-1443.
89. Miyajima A, Mui AL, Ogorochi T, Sakamaki K 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974.
90. Miyajima A, Mui AL, Ogorochi T, Sakamaki K 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974.
91. Modlin RL, Nutman TB 1993. Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol 5: 511-517.
92. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB 1992. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in brochial biopsies from atopic asthma. Clin Exp Allergy 22: 265-273.
93. Moser R, Fehr J, Bruijnzeel PLB 1992. IL-4 controls the selective endothelium driven transmigration of eosinophils from allergic individuals. J Immunol 149: 1432-1438.
94. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K 1993. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 48 (17 Suppl): 98-106.
95. Mui AL, Wakao H, Harada N, O'Farrell AM, Miyajima A 1995. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J Leuk Biol 57: 799-803.
96. Murata, Y, Takaki S, Migita S, Kikuchi Y, Tominaga A, Takatsu K 1992. Molecular cloning and expression of the human interleukin-5 receptor. J Exp Med 175: 341-351.
97. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y, Takatsu K 1993. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sciences. 53: Pl 243-247.
98. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S 1992. CD4+ T-lymphocytes and interieukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 146: 374-377.
99. Naora H, Young IG 1995. Comparison of the mechanisms regulating IL-5, IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1. Exp Hematol 23: 597-602.
100. Nicola NA 1989. Hemopoietic cell growth factors and their receptors. Ann Rev Biochem 58: 45-77.
101. Noelle R, Snow EC 1992. T helper cells. Curr Opin Immunol 4: 333-337.
102. Ogawa M 1994. Hematopoiesis. J Allergy & Clin Immunol 94: 645-650.
103. Ohnishi T, Sur S, Collins DS, Fish JE, Gleich GJ, Peters SP 1993. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J Allergy & Clin Immunol 92: 607-615.
104. Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K 1995. Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by downregulation of interleukin-5 gene transcription. Internat Arch Allergy & Immunol 107: 255-258.
105. Olivenstein R, Renzi PM, Yang JP, Rossi P, Laberge S, Waserman S, Martin JG 1993. Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest 92: 1477-1482.
106. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 181: 1827-1834.
107. Pene J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, De Vries JE 1988. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 18: 929-935.
108. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339: 64-67.
109. Pradalier A 1993. Late-phase reaction in asthma: basic mechanisms. Internat Arch Allergy & Immunol 101: 322-325.
110. Purkerson JM, Isakson PC 1992. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE. J Exp Med 175: 973-982.
111. Quan SF, Sedgwick JB, Nelson MV, Busse WW 1993. Corticosteroid resistance in eosinophilic gastritisrelation to in vitro eosinophil survival and interleukin 5. Annals of Allergy 70: 256-260.
112. Renzi PM, Du T, Sapienza S, Wang NS, Martin JG 1991. Acute effects of interleukin-2 on lung mechanics and airway responsiveness in rats. Am Rev Respir Dis 143: 380-385.
113. Renzi PM, Sapienza S, Du T, Wang NS, Martin JG 1991. Lymphokine-induced airway hyperresponsiveness in the rat. Am Rev Respir Dis 143: 375-379.
114. Renzi PM, Olivenstein R, Martin JG 1993. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Respir Dis 147: 967-974.
115. Renzi PM, Yang JP, Yasruel Z, Al Assaad S, Hamid Q 1996. Cytokine expression in the presence or absence of late airway responses after antigen challenge of sensitized rats. Am J Respir Cell Mol Biol 15: 367-373.
116. Robinson DS, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR 1993. Activation of CD4+ T cells increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 92: 313-324.
117. Robinson D, Hamid Q, Ying S, Bentley A, Assoufi B, Durham S, Kay AB 1993. Prednisone treatment in asthma is associated with modulation of bronchoalveolar lavage cell Interleukin-4, Interleukin-5, and Interferon-g cytokine gene expression. Am Rev Respir Dis 148: 401-406.
118. Robinson DS, Ying S., Bentley AM, Meng Q, North J, Durham SR, Kay AB, Hamid Q 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 92: 397-403.
119. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB 1992.Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304.
120. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, Vanderijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Molecular Medicine 2: 334-348.
121. Sanderson CJ 1992. Pharmacological implications of interleukin-5 in the control of eosinophilia. Advances in Pharmacol 23: 163-177.
122. Sanderson CJ 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
123. Sakamaki K, Miyajima I, Kitamura T, Miyajima A 1992. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO Journal 11: 3541-3549.
124. Satoh T, Sun L, Li MS, Spry CJ 1994. Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome. Immunol 83: 308-812.
125. Schrezenmeier H, Thome SD, Tewald F, Fleischer B, Raghavachar A 1993. Interleukin-5 is the predominant eosinophilopotetin produced by cloned T lymphocytes in hypereosinophilic syndrome. Experimental Hematol 21: 358-365.
126. Sedgwick JB, Quan SF, Calhoun WJ, Busse WW 1995. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy & Clin Immunol 96: 375-385.
127. Sewell WA, Mu HH1996. Dissociation of production of interleukin-4 and interleukin-5. Immunol & Cell Biol 74: 274-277.
128. Sur S, Gleich GJ, Swanson MC, Bartemes KR, Broide DH 1995. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy & Clin Immunol 96: 661-668.
129. Taha R, Kotsimbos T, Song YL, Schotman E, Menzies R, Hamid Q 1997. IFN-γ and IL-12 are increased in active vs. non-active pulmonary tuberculosis. Am J. Resp& Crit Care Med 155: 1135-1139.
130. Takagi M, Hara T, Ichihara M, Takatsu K, Miyajima A 1995. Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively. J Exp Med 181: 889-899.
131. Takai S, Yamada K, Hirayama N, Miyajima A, Taniyama T 1994. Mapping of the human gene encoding the mutual signal-transducing subunit (beta-chain) of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and interleukin-5 (IL-5) receptor complexes to chromosome 22q13.1. Human Genetics 93: 198-200.
132. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K 1993. Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med 177: 1523-1529.
133. Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R 1992. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor subunit. Proc Natl Acad Sci 89: 7041-7045 .
134. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G 1991. A human high affinity interleukin-5 receptor (IL-5) is composed of an IL-5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 66: 1175-1184.
135. Till S, Li B, Durham S, Humbert M, Assoufi B, Huston D, Dickason R, Jeannin P, Kay AB, Corrigan C 1995. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 25: 2727-2731.
136. Tuypens T, Plaetinck G, Baker E, Sutherland G, Brusselle G, Fiers W, Devos R, Tavernier J 1992. Organization and chromosomal localization of the human interleukin 5 receptor alpha-chain gene. Euro Cytokine Network 3: 451-459.
137. Van der Bruggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JA, Lammers JW, Koenderman L 1995. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood 85: 1442-1448.
138. Van Oosterhout AJ, Ladenius AR, Savelkoul HF, Van Ark I, Delsman KC, Nijkamp FP 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 147: 548-552.
139. Van Oosterhout AJ, Fattah D, Van Ark I, Hofman G, Buckley TL, Nijkamp FP 1995. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J Allergy & Clinical Immunol 96: 104-112.
140. Van Straaten JF, Dokter WH, Stulp BK, Vellenga E 1994. The regulation of interleukin 5 and interleukin 3 gene expression in human T cells. Cytokine 6: 229-234.
141. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Critical Care Med 150: 1038-1048.
142. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146: 109-115.
143. Walker C, Kaegi MK, Braun P, Blaser K 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 88: 935-942.
144. Watanabe A, Rossi P, Renzi PM, Xu LJ, Guttmann RD, Martin JG 1995. Adoptive transfer of allergic airway responses with sensitized lymphocytes in BN rats. Am J Respir & Critical Care Med 152: 64-70.
145. Watanabe A, Mishima H, Renzi PM, Xu LJ, Hamid Q, Martin JG 1995. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. J Clin Invest 96: 1303-1310.
146. Watanabe A, Mishima H, Kotsimbos ATC, Renzi PM, Martin JG, Hamid Q 1997. Adoptively transferred late allergic airway responses are associated with Th2 type cytokines in the rat. Am J Respir Crit Care Med 16: 69-74.
147. Weller PF 1992. Cytokine regulation of eosinophil function. Clinical Immunol & Immunopathol 62: S55-59.
148. Wiggs BR, Bosken C, Paré PD, Hogg JC 1992. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 145: 1251-1258.
149. Yamagata T, Nishida J, Sakai R, Tanaka T, Honda H, Hirano N, Mano H, Yazaki Y, Hirai H 1995. Of the GATA-binding proteins, only GATA-4 selectively regulates the human interleukin-5 gene promoter in interleukin-5-producing cells which express multiple GATA-binding proteins. Molecular & Cellular Biology 15: 3830-3839.
150. Yamaguchi S, Nagai H, Tanaka H, Tsujimoto M, Tsuruoka N. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sciences 54: 471-475.
151. Yamaguchi, Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 167: 1737-1742.
152. Yamaguchi N, Hitoshi Y, Takaki S, Murata Y, Migita M, Kamiya T, Minowada J, Tominaga A, Takatsu K 1991. Murine interleukin 5 receptor isolated by immunoaffinity chromatography: comparison of determined N-terminal sequence and deduced primary sequence from cDNA and implication of a role of the intracytoplasmic domain. Internat Immunol 3: 889-98.
153. Yang LP, Byun DG, Demeure CE, Vezzio N, Delespesse G 1995. Default development of cloned human naive CD4 T cells into interleukin-4- and interleukin-5- producing effector cells. Eur J Immunol 25: 3517-3520.
154. Yasruel Z, Humbert M, Kotsimbos ATC, Ploysongsang Y, Minshall E, Durham S, Pfister R, Menz G, Tavermer J, Kay AB, Hamid Q 1997. Expression of membrane-bound and soluble interleukin-5 alpha receptor mRNA in the bronchial mucosa of atopic & non-atopic asthmatics. Am J Resp Crit Care Med 155: 1413-1418.
155. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell & Mol Biol 12: 477-487.
156. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, Lowhagen O, Moqbel R, Kay AB, Hamid Q 1993. T cells are the principal source of interleukin-5 inRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 9: 356-360.
157. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, Lowhagen O, Moqbel R, Kay AB, Hamid QA 1993. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 9: 356-360.
158. Zanders ED 1994. Interleukin-5 receptor alpha chain mRNA is downregulated by transforming growth factor-β1. Soluble or membrane-anchored? Eur Cytokine Network 5: 419-422.
159. Zon LI, Yamaguchi Y, Yee K, Albee EA, Kimura A, Bennett JC, Orkin SH, Ackerman SJ 1993. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 81: 3234-3241.